566 related articles for article (PubMed ID: 23647352)
1. Hemoglobinopathy carrier prevalence in the United Arab Emirates: first analysis of the Dubai Health Authority premarital screening program results.
Belhoul KM; Abdulrahman M; Alraei RF
Hemoglobin; 2013; 37(4):359-68. PubMed ID: 23647352
[TBL] [Abstract][Full Text] [Related]
2. Misdiagnosis of Hb D-Punjab/β-thalassemia is a potential pitfall in hemoglobinopathy screening programs: a case report.
Belhoul KM; Bakir ML; Abdulrahman M
Hemoglobin; 2013; 37(2):119-23. PubMed ID: 23425159
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of β-thalassemia in the United Arab Emirates.
Baysal E
Hemoglobin; 2011; 35(5-6):581-8. PubMed ID: 22074124
[TBL] [Abstract][Full Text] [Related]
4. Ten Years of Routine α- and β-Globin Gene Sequencing in UK Hemoglobinopathy Referrals Reveals 60 Novel Mutations.
Henderson SJ; Timbs AT; McCarthy J; Gallienne AE; Proven M; Rugless MJ; Lopez H; Eglinton J; Dziedzic D; Beardsall M; Khalil MS; Old JM
Hemoglobin; 2016; 40(2):75-84. PubMed ID: 26635043
[TBL] [Abstract][Full Text] [Related]
5. Report on Ten Years' Experience of Premarital Hemoglobinopathy Screening at a Center in Antalya, Southern Turkey.
Canatan D; Delibas S
Hemoglobin; 2016 Aug; 40(4):273-6. PubMed ID: 27207683
[TBL] [Abstract][Full Text] [Related]
6. The clinical and laboratory spectrum of Hb C [β6(A3)Glu→Lys, GAG>AAG] disease.
Cook CM; Smeltzer MP; Mortier NA; Kirk SE; Despotovic JM; Ware RE; Hankins JS
Hemoglobin; 2013; 37(1):16-25. PubMed ID: 23297836
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and molecular analysis of β-thalassemia in Adiyaman, Turkey.
Genc A; Tastemir Korkmaz D; Buyukleyla M; Celiker M
Hemoglobin; 2012; 36(2):131-8. PubMed ID: 22356097
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of β-thalassemia trait and abnormal hemoglobins in Sanliurfa Province in southeast Turkey.
Incebiyik A; Genc A; Hilali NG; Camuzcuoglu A; Camuzcuoglu H; Kilic A; Vural M
Hemoglobin; 2014; 38(6):402-4. PubMed ID: 25405917
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of hemoglobinopathies in rural Bengal, India.
Dolai TK; Dutta S; Bhattacharyya M; Ghosh MK
Hemoglobin; 2012; 36(1):57-63. PubMed ID: 22004064
[TBL] [Abstract][Full Text] [Related]
10. Molecular epidemiological survey of hemoglobinopathies in the Wuxi region of Jiangsu Province, eastern China.
Lin M; Han ZJ; Wang Q; Zheng L; Wang Y; Yang H; Huang Y; Lin F; Zhan XF; Lin CP; Wu JR; Luo ZY; Liu JB; Yan ZH; Zheng SY; Zheng JK; Lu M; Zhu JJ; Xie LX; Yang LY
Hemoglobin; 2013; 37(5):454-66. PubMed ID: 23806067
[TBL] [Abstract][Full Text] [Related]
11. Micromapping of thalassemia and hemoglobinopathies in diferent regions of northeast Thailand and Vientiane, Laos People's Democratic Republic.
Tritipsombut J; Sanchaisuriya K; Phollarp P; Bouakhasith D; Sanchaisuriya P; Fucharoen G; Fucharoen S; Schelp FP
Hemoglobin; 2012; 36(1):47-56. PubMed ID: 22122810
[TBL] [Abstract][Full Text] [Related]
12. Premarital hemoglobinopathy screening in Kayseri: a city in Middle Anatolia region of Turkey.
Karakukcu C; Kocer D; Altuner Torun Y; Karakukcu M; Yokus O; Ozdemir MA; Patiroglu T
J Pediatr Hematol Oncol; 2012 Mar; 34(2):e49-52. PubMed ID: 22246155
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of Hemoglobinopathies in the Huzhou Region, Zhejiang Province, Southeast China.
Ding ZY; Shen GS; Zhang S; He PY
Hemoglobin; 2016 Sep; 40(5):304-309. PubMed ID: 27615034
[TBL] [Abstract][Full Text] [Related]
14. Thalassemia and hemoglobinopathies in Thua Thien Hue Province, Central Vietnam.
Nguyen HV; Sanchaisuriya K; Nguyen D; Phan HT; Siridamrongvattana S; Sanchaisuriya P; Fucharoen S; Fucharoen G; Schelp FP
Hemoglobin; 2013; 37(4):333-42. PubMed ID: 23600535
[TBL] [Abstract][Full Text] [Related]
15. Hemoglobinopathies in the Çukurova Region and Neighboring Provinces.
Yuzbasioglu Ariyurek S; Yildiz SM; Yalin AE; Guzelgul F; Aksoy K
Hemoglobin; 2016 Jun; 40(3):168-72. PubMed ID: 26984585
[TBL] [Abstract][Full Text] [Related]
16. Implications of Population Screening for Thalassemias and Hemoglobinopathies in Rural Areas of West Bengal, India: Report of a 10-Year Study of 287,258 Cases.
Maji SK; Dolai TK; Pradhan S; Maity A; Mandal S; Mondal T; Manna S; Mandal PK
Hemoglobin; 2020 Nov; 44(6):432-437. PubMed ID: 33059511
[TBL] [Abstract][Full Text] [Related]
17. Spectrum of β-Thalassemia and Other Hemoglobinopathies in the Saurashtra Region of Gujarat, India: Analysis of a Large Population Screening Program.
Vachhani NA; Vekariya DJ; Colah RB; Kashiyani HN; Nandani SL
Hemoglobin; 2022 Sep; 46(5):285-289. PubMed ID: 36367309
[TBL] [Abstract][Full Text] [Related]
18. Molecular lesion frequency of hemoglobin gene disorders in Taiwan.
Liu SC; Peng CT; Lin TH; Wang SJ; Shih MC; Tien N; Chang CC; Lu JJ; Lin CY
Hemoglobin; 2011; 35(3):228-36. PubMed ID: 21599435
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of hemoglobin disorders and glucose-6-phosphate dehydrogenase (G6PD) deficiency in the Republic of Guinea (West Africa).
Millimono TS; Loua KM; Rath SL; Relvas L; Bento C; Diakite M; Jarvis M; Daries N; Ribeiro LM; Manco L; Kaeda JS
Hemoglobin; 2012; 36(1):25-37. PubMed ID: 21929367
[TBL] [Abstract][Full Text] [Related]
20. Molecular Characterization and Hematological Aspects of Hb E-Myanmar [β26(B8)Glu→Lys and β65(E9)Lys→Asn,
Satthakarn S; Boonmee S; Panyasai S
Hemoglobin; 2020 Nov; 44(6):385-390. PubMed ID: 33222574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
